Veana Therapeutics
Portland, US · Founded 2015 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
FA
F Andrew RayDirector
MF
Mark F HoliferExecutive Officer, Director, Promoter
EA
Emmanuel AkporiayeExecutive Officer, Director, Promoter
RA
Rebecca AkporiayeExecutive Officer, Director
AD
Andrew D ThalerExecutive Officer
DR
Denis R BurgerDirector
TE
Thomas E McChesneyExecutive Officer
TD
Trent D DavisDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$831KraisedNov 2020 · 4 investors · PharmaceuticalsRule 506(b)
▶$831KraisedNov 2020 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- EMMANUEL AKPORIAYEExecutive Officer, Director
- SANDRA SHOTWELLDirector
- REBECCA AKPORIAYEExecutive Officer, Director
- BRUCE RAMSEYERDirector
- ANDREW RAYDirector
- Offering amount
- $1.3M
- Amount sold
- $831K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 04, 06b
▶$542KraisedMay 2018 · 9 investors · BiotechnologyRule 506(b)
▶$542KraisedMay 2018 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- F Andrew RayDirector
- Mark F HoliferExecutive Officer, Director, Promoter
- Emmanuel AkporiayeExecutive Officer, Director, Promoter
- Rebecca AkporiayeExecutive Officer, Director
- Andrew D ThalerExecutive Officer
- Denis R BurgerDirector
- Thomas E McChesneyExecutive Officer
- Trent D DavisDirector
- Offering amount
- $2M
- Amount sold
- $542K
- Minimum investment
- $5K
- Proceeds to insiders
- $100K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $400K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $350.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.